ULTRA RAPID LISPRO (URLI) DEMONSTRATES SIMILAR TIME IN TARGET RANGE TO LISPRO WITH THE MEDTRONIC MINIMED 670G HYBRID CLOSED-LOOP SYSTEM

被引：0
|
作者：
Carlson, A. [1 ]
Liu, R. [2 ]
Hardy, T. [3 ]
Boyd, J. [4 ]
Bergenstal, R.
Morrett, S. [5 ]
Ignaut, D. [3 ]
机构：
[1] Int Diabet Ctr, Endocrinol, Minneapolis, MN USA
[2] Eli Lilly & Co, Global Stat Sci, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Med Dev, Indianapolis, IN 46285 USA
[4] Atlanta Diabet Associates, Endocrinol, Atlanta, GA USA
[5] Eli Lilly & Co, Clin Dev Diabet, Indianapolis, IN 46285 USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P035 / #13
引用
收藏
页码：A85 / A86
页数：2
相关论文
共 48 条
  • [21] Glycemic control outcomes of adults using the MiniMed™ 670G hybrid closed-loop (HCL) system: A single-center study
    Al Qifari, S. F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 158
  • [22] HYBRID CLOSED-LOOP CONTROL USING THE MEDTRONIC 670G AND ENLITE3 SYSTEM IN TYPE 1 DIABETES AT DIABETES CAMP
    Ly, T.
    Roy, A.
    Grosman, B.
    Shin, J.
    Campbell, A.
    Monirabbasi, S.
    Liang, B.
    Shanmugham, S.
    Clinton, P.
    Buckingham, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A20 - A20
  • [23] Increased time in range and sustained AutoMode use in 670G hybrid closed-loop system users: real world experience in DIABETER
    Mul, D.
    Arrieta, A.
    Dekker, P.
    Birnie, E.
    Sas, T. C. J.
    Aanstoot, H. -J.
    Veeze, H. J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S86 - S86
  • [24] TIME IN TARGET GLUCOSE RANGE AND GLYCATED HEMOGLOBIN LEVELS DURING THE MINIMED 670G SYSTEM PIVOTAL TRIALS
    Shin, J.
    Liu, M.
    Chen, X.
    Cordero, T.
    Lee, S.
    Kaufman, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A85 - A86
  • [25] ENLITE3 CONTINUOUS GLUCOSE SENSOR ACCURACY DURING INPATIENT AND OUTPATIENT HYBRID CLOSED-LOOP CONTROL WITH MEDTRONIC 670G SYSTEM
    Buckingham, B.
    Shah, R.
    Shin, J.
    Shanmugham, S.
    Clinton, P.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A72 - A73
  • [26] Adjusting Therapy Profiles When Switching to Ultra-Rapid Lispro in an Advanced Hybrid Closed-Loop System: An in Silico Study
    Colmegna, Patricio
    Diaz, C. Jenny L.
    Garcia-Tirado, Jose
    DeBoer, Mark D.
    Breton, Marc D.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024, 18 (03): : 676 - 685
  • [27] Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes
    Jendle, Johan
    Pohlmann, Johannes
    de Portu, Simona
    Smith-Palmer, Jayne
    Roze, Stephane
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (03) : 110 - 118
  • [28] Comparison of Six Months Experience on Hybrid Closed Loop MiniMed 670G System and Advanced Hybrid Closed Loop MiniMed 780G System Using a Structured Initiation Protocol in Children and Adolescents with Type 1 Diabetes
    Petrovski, Goran
    Campbell, Judith
    Alkhalaf, Fawziya
    Hussain, Khalid
    DIABETES, 2022, 71
  • [29] Reduced meal Bolusing burden and improved sleep for caregivers during pediatric use of the MiniMed™ 780g advanced hybrid closed-loop (aHCL) system with ultra-rapid insulin lispro-aabc
    McVean, J.
    Cordero, T.
    Niu, F.
    Yovanovich, C.
    Huang, S.
    Shin, J.
    Rhinehart, A.
    Vigersky, R.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 309 - 309
  • [30] CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Lispro Compared with Standard Lispro in Adults with Type 1 Diabetes: A Double-Blind, Randomized, Crossover Study
    Nwokolo, Munachiso
    Lakshman, Rama
    Hartnell, Sara
    Alwan, Heba
    Ware, Julia
    Allen, Janet M.
    Wilinska, Malgorzata E.
    Evans, Mark L.
    Hovorka, Roman
    Boughton, Charlotte K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 856 - 863
12345